Kirk Morris
Impact in
- Hematology top 10%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
-
- Hemoglobinopathies and Related Disorders
Papers in
- Hematology 16
- Acute Myeloid Leukemia Research 11
- Hematopoietic Stem Cell Transplantation 5
- Chronic Myeloid Leukemia Treatments 3
- Oncology 10
- Cancer Risks and Factors 5
- Neutropenia and Cancer Infections 3
- Co-authors
- Glen Kennedy (18 shared papers)Peter Mollee (9 shared papers)Joseph R. Casey (1 shared paper)Paula Marlton (7 shared papers)A. J. Beddall (1 shared paper)Saad Al‐Ismail (1 shared paper)Roger Munro (1 shared paper)Kathryn Jackson (7 shared papers)
- Journals
- Blood (8 papers)British Journal of Haematology (3 papers)Transfusion (1 paper)HemaSphere (1 paper)Diagnostic Cytopathology (1 paper)
- Partner nations
- AustraliaNew ZealandUnited States
In The Last Decade
Kirk Morris
30 papers receiving 254 citations
Peers
Comparison fields: 5 of 72
- Hematology 69
- Genetics 32
- Oncology 59
- Epidemiology 49
- Public Health, Environmental and Occupational Health 28
Countries citing papers authored by Kirk Morris
This map shows the geographic impact of Kirk Morris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kirk Morris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kirk Morris more than expected).
Fields of papers citing papers by Kirk Morris
This network shows the impact of papers produced by Kirk Morris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kirk Morris. The network helps show where Kirk Morris may publish in the future.
Co-authors
The 25 scholars most cited alongside Kirk Morris, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 53 | |
| 2 | 2013 | 38 | |
| 3 | 2013 | 25 | |
| 4 | Trade Flows and Marketing Practices within the United States Nursery Industry: 2003 | 2005 | 23 |
| 5 | 2007 | 21 | |
| 6 | 2010 | 20 | |
| 7 | 2013 | 8 | |
| 8 | 2004 | 8 | |
| 9 | 2017 | 7 | |
| 10 | 2018 | 7 | |
| 11 | 2015 | 7 | |
| 12 | 2004 | 7 | |
| 13 | 2022 | 6 | |
| 14 | 2011 | 6 | |
| 15 | 2014 | 6 | |
| 16 | 2016 | 4 | |
| 17 | 2021 | 3 | |
| 18 | 2018 | 2 | |
| 19 | Survival and prognostic factors amongst Australian patients with AL amyloidosis | 2010 | 1 |
| 20 | 2021 | 1 |
About Kirk Morris
Kirk Morris is a scholar working on Hematology, Oncology, Genetics, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health, having authored 33 papers that have together received 263 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (11 papers), Hematopoietic Stem Cell Transplantation (5 papers), Cancer Risks and Factors (5 papers), Acute Lymphoblastic Leukemia research (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), Chronic Myeloid Leukemia Treatments (3 papers), Childhood Cancer Survivors' Quality of Life (3 papers) and Neutropenia and Cancer Infections (3 papers). The work is most often cited by research in Hematology (69 citations), Genetics (32 citations), Oncology (59 citations), Epidemiology (49 citations) and Public Health, Environmental and Occupational Health (28 citations). Kirk Morris has collaborated with scholars based in Australia, New Zealand and United States. Frequent co-authors include Glen Kennedy, Peter Mollee, Joseph R. Casey, Paula Marlton, A. J. Beddall, Saad Al‐Ismail, Roger Munro, Kathryn Jackson, Devinder Gill and John J. Haydu. Their work appears in journals such as Blood, British Journal of Haematology, Transfusion, HemaSphere and Diagnostic Cytopathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.